The latest closing stock price for Corvus Pharmaceuticals as of January 21, 2025 is 5.22.
An investor who bought $1,000 worth of Corvus Pharmaceuticals stock at the IPO in 2016 would have $-634 today, roughly -1 times their original investment - a -10.56% compound annual growth rate over 9 years.
The all-time high Corvus Pharmaceuticals stock closing price was 21.37 on March 27, 2017.
The Corvus Pharmaceuticals 52-week high stock price is 10.00, which is 91.6% above the current share price.
The Corvus Pharmaceuticals 52-week low stock price is 1.30, which is 75.1% below the current share price.
The average Corvus Pharmaceuticals stock price for the last 52 weeks is 3.96.
An investor who bought $1,000 worth of Corvus Pharmaceuticals stock at the IPO in 2016 would have $-634 today, roughly -1 times their original investment - a -10.56% compound annual growth rate over 9 years.
The all-time high Corvus Pharmaceuticals stock closing price was 21.37 on March 27, 2017.
The Corvus Pharmaceuticals 52-week high stock price is 10.00, which is 91.6% above the current share price.
The Corvus Pharmaceuticals 52-week low stock price is 1.30, which is 75.1% below the current share price.
The average Corvus Pharmaceuticals stock price for the last 52 weeks is 3.96.